(WMS) Advanced Drainage Systems - Overview
Stock: Pipe, Chambers, Septic, Fittings, Fabric
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.55% |
| Yield on Cost 5y | 0.72% |
| Yield CAGR 5y | 13.62% |
| Payout Consistency | 93.8% |
| Payout Ratio | 14.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 37.2% |
| Relative Tail Risk | -10.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.09 |
| Alpha | 35.59 |
| Character TTM | |
|---|---|
| Beta | 1.067 |
| Beta Downside | 0.921 |
| Drawdowns 3y | |
|---|---|
| Max DD | 45.75% |
| CAGR/Max DD | 0.54 |
Description: WMS Advanced Drainage Systems January 06, 2026
Advanced Drainage Systems, Inc. (NYSE: WMS) designs, manufactures, and markets thermoplastic corrugated pipe and related water-management solutions across the United States, Canada, and other international markets. The firm operates through four segments-Pipe, Infiltrator, International, and Allied Products & Other-offering single-, double-, and triple-wall polypropylene and polyethylene corrugations, leach-field chambers, EZflow synthetic-aggregate bundles, mechanical-aeration wastewater systems, septic tanks, and a suite of PVC, rubber, and stainless-steel accessories for residential, non-residential, agricultural, and infrastructure applications.
In the most recent fiscal year, WMS reported revenue of roughly $2.0 billion, a 12 % YoY increase driven by higher demand for storm-water infrastructure tied to the U.S. Infrastructure Investment and Jobs Act. The company’s gross margin expanded to 38 % as it leveraged scale in its polypropylene pipe line, while its operating cash flow exceeded $300 million, underscoring strong free-cash-generation capacity. A key sector catalyst remains the growing emphasis on resilient water-management systems amid climate-related precipitation variability, which is expected to sustain multi-year growth in both new-construction and retrofit markets.
For a deeper, data-driven view of WMS’s valuation dynamics and scenario analysis, you might explore the company’s profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 458.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 1.77 > 1.0 |
| NWC/Revenue: 39.91% < 20% (prev 35.16%; Δ 4.75% < -1%) |
| CFO/TA 0.18 > 3% & CFO 741.0m > Net Income 458.3m |
| Net Debt (618.1m) to EBITDA (877.7m): 0.70 < 3 |
| Current Ratio: 3.48 > 1.5 & < 3 |
| Outstanding Shares: last quarter (78.3m) vs 12m ago 0.26% < -2% |
| Gross Margin: 38.12% > 18% (prev 0.39%; Δ 3773 % > 0.5%) |
| Asset Turnover: 78.44% > 50% (prev 82.42%; Δ -3.98% > 0%) |
| Interest Coverage Ratio: 7.56 > 6 (EBITDA TTM 877.7m / Interest Expense TTM 92.0m) |
Altman Z'' 5.45
| A: 0.29 (Total Current Assets 1.67b - Total Current Liabilities 480.9m) / Total Assets 4.08b |
| B: 0.43 (Retained Earnings 1.76b / Total Assets 4.08b) |
| C: 0.18 (EBIT TTM 695.4m / Avg Total Assets 3.81b) |
| D: 0.85 (Book Value of Equity 1.83b / Total Liabilities 2.15b) |
| Altman-Z'' Score: 5.45 = AAA |
Beneish M -2.96
| DSRI: 1.09 (Receivables 400.5m/357.6m, Revenue 2.99b/2.91b) |
| GMI: 1.02 (GM 38.12% / 39.06%) |
| AQI: 1.03 (AQ_t 0.32 / AQ_t-1 0.31) |
| SGI: 1.02 (Revenue 2.99b / 2.91b) |
| TATA: -0.07 (NI 458.3m - CFO 741.0m) / TA 4.08b) |
| Beneish M-Score: -2.96 (Cap -4..+1) = A |
What is the price of WMS shares?
Over the past week, the price has changed by +15.35%, over one month by +17.31%, over three months by +19.79% and over the past year by +49.85%.
Is WMS a buy, sell or hold?
- StrongBuy: 7
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the WMS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 175.9 | 0.3% |
| Analysts Target Price | 175.9 | 0.3% |
| ValueRay Target Price | 201 | 14.6% |
WMS Fundamental Data Overview February 02, 2026
P/E Forward = 22.6757
P/S = 3.9588
P/B = 6.2419
P/EG = 1.3353
Revenue TTM = 2.99b USD
EBIT TTM = 695.4m USD
EBITDA TTM = 877.7m USD
Long Term Debt = 1.25b USD (from longTermDebt, last quarter)
Short Term Debt = 49.5m USD (from shortTermDebt, last quarter)
Debt = 1.43b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 618.1m USD (from netDebt column, last quarter)
Enterprise Value = 12.44b USD (11.82b + Debt 1.43b - CCE 812.9m)
Interest Coverage Ratio = 7.56 (Ebit TTM 695.4m / Interest Expense TTM 92.0m)
EV/FCF = 23.51x (Enterprise Value 12.44b / FCF TTM 529.2m)
FCF Yield = 4.25% (FCF TTM 529.2m / Enterprise Value 12.44b)
FCF Margin = 17.72% (FCF TTM 529.2m / Revenue TTM 2.99b)
Net Margin = 15.35% (Net Income TTM 458.3m / Revenue TTM 2.99b)
Gross Margin = 38.12% ((Revenue TTM 2.99b - Cost of Revenue TTM 1.85b) / Revenue TTM)
Gross Margin QoQ = 40.00% (prev 39.82%)
Tobins Q-Ratio = 3.05 (Enterprise Value 12.44b / Total Assets 4.08b)
Interest Expense / Debt = 1.62% (Interest Expense 23.1m / Debt 1.43b)
Taxrate = 25.08% (52.4m / 208.9m)
NOPAT = 521.0m (EBIT 695.4m * (1 - 25.08%))
Current Ratio = 3.48 (Total Current Assets 1.67b / Total Current Liabilities 480.9m)
Debt / Equity = 0.75 (Debt 1.43b / totalStockholderEquity, last quarter 1.91b)
Debt / EBITDA = 0.70 (Net Debt 618.1m / EBITDA 877.7m)
Debt / FCF = 1.17 (Net Debt 618.1m / FCF TTM 529.2m)
Total Stockholder Equity = 1.71b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.04% (Net Income 458.3m / Total Assets 4.08b)
RoE = 26.83% (Net Income TTM 458.3m / Total Stockholder Equity 1.71b)
RoCE = 23.52% (EBIT 695.4m / Capital Employed (Equity 1.71b + L.T.Debt 1.25b))
RoIC = 17.55% (NOPAT 521.0m / Invested Capital 2.97b)
WACC = 8.92% (E(11.82b)/V(13.25b) * Re(9.85%) + D(1.43b)/V(13.25b) * Rd(1.62%) * (1-Tc(0.25)))
Discount Rate = 9.85% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.18%
[DCF Debug] Terminal Value 75.05% ; FCFF base≈475.9m ; Y1≈483.2m ; Y5≈527.5m
Fair Price DCF = 92.89 (EV 7.84b - Net Debt 618.1m = Equity 7.22b / Shares 77.8m; r=8.92% [WACC]; 5y FCF grow 1.26% → 2.90% )
EPS Correlation: -14.55 | EPS CAGR: -33.25% | SUE: -4.0 | # QB: 0
Revenue Correlation: 3.29 | Revenue CAGR: 4.72% | SUE: 1.50 | # QB: 2
EPS next Year (2027-03-31): EPS=6.45 | Chg30d=-0.013 | Revisions Net=+4 | Growth EPS=+7.9% | Growth Revenue=+7.3%